At 3.2% CAGR, the Middle East & Africa Intracranial pressure monitoring Devices Market is projected to be worth US$ 79.10 million by 2028, says The Business Market Insights

According to the Business Market Insights’ research, the Middle East & Africa intracranial pressure monitoring devices market was valued at US$ 67.41 million in 2023 and is expected to reach US$ 79.10 million by 2028, registering a CAGR of 3.2% from 2023 to 2028. Increasing prevalence of neurological diseases and rising incidence of traumatic brain injuries (TBIs) are the critical factors attributed to the Middle East & Africa intracranial pressure monitoring devices market expansion.

Intracranial pressure (ICP) monitoring is crucial in diagnosing and treating neurological diseases such as subarachnoid and intracerebral hemorrhage, ischemic stroke, hydrocephalus, and meningitis/encephalitis. Bleeding in the brain, tumor, stroke, aneurysm, high blood pressure, or brain infection can lead to fluctuations in intracranial pressure. High ICP can cause headaches, blurred vision, vomiting, and other serious complications such as seizures, neurological damage, and death. Around 11% of all ischemic stroke cases occur in patients aged 15–49 years, and more than 58% occur in people under 70. Also, 55% of all ischemic stroke cases occur in women and 45% in men. Thus, the increasing prevalence of neurological diseases drives the growth of the Middle East & Africa Intracranial pressure (ICP) monitoring devices market.

On the contrary, limitations associated with ICP monitors hurdles the growth of Middle East & Africa intracranial pressure monitoring devices market. 

Based on offering, the Middle East & Africa intracranial pressure monitoring devices market is segmented into product & systems, solutions & platform, and services. The products and systems held 67.5% market share in 2023, amassing US$ 45.50 million. It is projected to garner US$ 52.64 million by 2028 to expand at 3.0% CAGR during 2023–2028.

Based on type, the Middle East & Africa intracranial pressure monitoring devices market is segmented into invasive and non-invasive. The invasive segment held 81.2% market share in 2023, amassing US$ 54.76 million. It is projected to garner US$ 63.66 million by 2028 to expand at 3.1% CAGR during 2023–2028.

Based on application, the Middle East & Africa intracranial pressure monitoring devices market is segmented into traumatic brain injuries, reye’s syndrome, non-traumatic bleeds, hydrocephalus, space-occupying lesions, cerebral oedema, and others. The traumatic brain injuries held 35.9% market share in 2023, amassing US$ 24.18 million. It is projected to garner US$ 28.07 million by 2028 to expand at 3.0% CAGR during 2023–2028.

Based on end user, the Middle East & Africa intracranial pressure monitoring devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held 58.5% market share in 2023, amassing US$ 39.44 million. It is projected to garner US$ 45.97 million by 2028 to expand at 3.1% CAGR during 2020–2028.

Based on country, the Middle East & Africa intracranial pressure monitoring devices market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that the Saudi Arabia captured 33.9% market share in 2023. It was assessed at US$ 22.82 million in 2023 and is likely to hit US$ 26.38 million by 2028, exhibiting a CAGR of 2.9% during the forecast period.     

Key players dominating the Middle East & Africa intracranial pressure monitoring market are RAUMEDIC AG; Integra LifeSciences Holdings Corp; Medtronic Plc; and NovaSignal Corp among others.   

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com